Neuca S.A.
NEUCA S.A. engages in the wholesale distribution of pharmaceuticals in Poland. It operates through Wholesale Distribution of Medicines, Manufacture of Pharmaceuticals, Medical Operator, Clinical Trials, and Insurance Activities segments. The company offers Rx, OTC drugs, dietary supplements, medical devices, dermocosmetics, hygiene products, personal protective equipment, as well as diagnostic an… Read more
Neuca S.A. (NEU) - Total Assets
Latest total assets as of September 2025: zł5.98 Billion PLN
Based on the latest financial reports, Neuca S.A. (NEU) holds total assets worth zł5.98 Billion PLN as of September 2025.
Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments.
Neuca S.A. - Total Assets Trend (2005–2024)
This chart illustrates how Neuca S.A.’s total assets have evolved over time, based on quarterly financial data. Explore and compare other companies by total assets.
Neuca S.A. - Asset Composition Analysis
Current Asset Composition (December 2024)
Neuca S.A.'s total assets of zł5.98 Billion consist of 64.7% current assets and 35.3% non-current assets.
| Asset Category | Amount (PLN) | % of Total Assets |
|---|---|---|
| Cash & Equivalents | zł0.00 | 2.0% |
| Accounts Receivable | zł1.80 Billion | 32.7% |
| Inventory | zł1.60 Billion | 29.1% |
| Property, Plant & Equipment | zł0.00 | 0.0% |
| Intangible Assets | zł149.99 Million | 2.7% |
| Goodwill | zł1.00 Billion | 18.2% |
Asset Composition Trend (2005–2024)
This chart illustrates how Neuca S.A.'s asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution.
Key Asset Composition Facts
- Current vs. Non-Current Assets: Neuca S.A.'s current assets represent 64.7% of total assets in 2024, a decrease from 88.7% in 2005.
- Cash Position: Cash and equivalents constituted 2.0% of total assets in 2024, up from 1.5% in 2005.
- Tangible vs. Intangible: Intangible assets (including goodwill) make up 20.0% of total assets, an increase from 0.0% in 2005.
- Asset Diversification: The largest asset category is accounts receivable at 32.7% of total assets.
Neuca S.A. Competitors by Total Assets
Key competitors of Neuca S.A. based on total assets are shown below.
| Company | Country | Total Assets |
|---|---|---|
|
C.Q. Pharmaceutical Holding Co Ltd
SHE:000950
|
China | CN¥67.71 Billion |
|
Shenzhen Glory Medical Co Ltd
SHE:002551
|
China | CN¥3.56 Billion |
|
Shandong Realcan Pharmaceutical Co Ltd
SHE:002589
|
China | CN¥15.33 Billion |
|
Hanmi Science
KO:008930
|
Korea | ₩1.45 Trillion |
|
BCM Alliance Bhd
KLSE:0187
|
Malaysia | RM147.86 Million |
|
Qingdao Baheal Medical INC.
SHE:301015
|
China | CN¥7.59 Billion |
|
Excelsior Medical Co Ltd
TW:4104
|
Taiwan | NT$18.80 Billion |
|
CHC Healthcare Group
TW:4164
|
Taiwan | NT$14.83 Billion |
Neuca S.A. - Asset Efficiency Metrics
Asset efficiency metrics measure how effectively a company uses its assets to generate revenue and profits. These indicators help investors evaluate management's ability to deploy capital efficiently.
Asset Turnover Ratio
Measures how efficiently a company uses its assets to generate sales
Strong asset utilization - Neuca S.A. generates 2.29x its asset value in annual revenue.
Return on Assets (ROA)
Measures how efficiently a company uses its assets to generate profits
Moderate ROA - For every $100 in assets, Neuca S.A. generates $ 2.80 in net profit.
Neuca S.A. - Liquidity and Working Capital Analysis
Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.
Key Liquidity Metrics
| Metric | Current | 1 Year Ago | 5 Years Ago |
|---|---|---|---|
| Current Ratio | 0.89 | 0.95 | 0.95 |
| Quick Ratio | 0.53 | 0.58 | 0.49 |
| Cash Ratio | 0.00 | 0.00 | 0.00 |
| Working Capital | zł-499.18 Million | zł -204.88 Million | zł -119.44 Million |
Neuca S.A. - Advanced Valuation Insights
This section examines the relationship between Neuca S.A.'s asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.
Key Valuation Metrics
| Current Price-to-Book Ratio | 3.44 |
| Latest Market Cap to Assets Ratio | 0.05 |
| Asset Growth Rate (YoY) | 6.5% |
| Total Assets | zł5.51 Billion |
| Market Capitalization | $279.51 Million USD |
Valuation Analysis
Below Book Valuation: The market values Neuca S.A.'s assets below their book value (0.05 x), which may indicate investor concerns about asset quality or future growth.
Positive Asset Growth: Neuca S.A.'s assets grew by 6.5% over the past year, showing continued investment in the company's operational capacity.
Annual Total Assets for Neuca S.A. (2005–2024)
The table below shows the annual total assets of Neuca S.A. from 2005 to 2024.
| Year | Total Assets | Change |
|---|---|---|
| 2024-12-31 | zł5.51 Billion | +6.47% |
| 2023-12-31 | zł5.18 Billion | +6.94% |
| 2022-12-31 | zł4.84 Billion | +17.56% |
| 2021-12-31 | zł4.12 Billion | +14.16% |
| 2020-12-31 | zł3.61 Billion | +5.71% |
| 2019-12-31 | zł3.41 Billion | +9.48% |
| 2018-12-31 | zł3.12 Billion | +7.07% |
| 2017-12-31 | zł2.91 Billion | +8.12% |
| 2016-12-31 | zł2.69 Billion | +0.37% |
| 2015-12-31 | zł2.68 Billion | +4.35% |
| 2014-12-31 | zł2.57 Billion | +33.99% |
| 2013-12-31 | zł1.92 Billion | +2.45% |
| 2012-12-31 | zł1.87 Billion | -4.99% |
| 2011-12-31 | zł1.97 Billion | -5.25% |
| 2010-12-31 | zł2.08 Billion | +2.54% |
| 2009-12-31 | zł2.03 Billion | +50.11% |
| 2008-12-31 | zł1.35 Billion | +18.26% |
| 2007-12-31 | zł1.14 Billion | +110.15% |
| 2006-12-31 | zł543.57 Million | +46.41% |
| 2005-12-31 | zł371.26 Million | -- |